Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A

Staphylococcus aureus is an important cause of infective endocarditis (IE) in patients without a history of prior heart valve damage. The ability to stimulate the activation of resting platelets and their subsequent aggregation is regarded as an important virulence factor of bacteria that cause IE. Clumping factor A is the dominant surface protein responsible for platelet activation by S. aureus cells in the stationary phase of growth. This study used Lactococcus lactis as a surrogate host to study the mechanism of ClfA‐promoted platelet activation. Expression of ClfA from a nisin‐inducible promoter demonstrated that a minimum level of surface‐expressed ClfA was required. Using platelets that were purified from plasma, the requirement for both bound fibrinogen and immunoglobulin was demonstrated. The immunoglobulin G (IgG) requirement is consistent with the potent inhibition of platelet activation by a monoclonal antibody specific for the platelet FcγRIIa receptor. Furthermore the IgG must contain antibodies specific for the ClfA A domain. A model is proposed whereby bacterial cells armed with a sufficient number of surface‐bound fibrinogen molecules can engage resting platelet glycoprotein GPIIb/IIIa, aided by bound IgG molecules, which encourages the clustering of FcγRIIa receptors. This can trigger activation of signal transduction leading to activation of GPIIb/IIIa and aggregation of platelets. In addition, analysis of a mutant of ClfA totally lacking the ability to bind fibrinogen revealed a second, although less efficient, mechanism of platelet activation. The fibrinogen‐independent pathway required IgG and complement deposition to trigger platelet aggregation

[1]  L. Visai,et al.  FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. , 2005, Blood.

[2]  J. Patti A humanized monoclonal antibody targeting Staphylococcus aureus. , 2004, Vaccine.

[3]  Barry S. Coller,et al.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics , 2004, Nature.

[4]  J. Vernachio,et al.  Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in an Experimental Model of Infective Endocarditis , 2003, Antimicrobial Agents and Chemotherapy.

[5]  Magnus Hook,et al.  A “dock, lock, and latch” Structural Model for a Staphylococcal Adhesin Binding to Fibrinogen , 2003, Cell.

[6]  M. Byrne,et al.  Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. , 2003, Gastroenterology.

[7]  S. Jackson,et al.  Intercellular calcium communication regulates platelet aggregation and thrombus growth , 2003, The Journal of cell biology.

[8]  Livia Visai,et al.  Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences. , 2003, Microbiology.

[9]  Sheila,et al.  Response of Human Platelets to Activating Monoclonal Antibodies : Importance of FcyRII ( CD 32 ) Phenotype and Level of Expression , 2003 .

[10]  M. Carson,et al.  A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen‐binding MSCRAMM, clumping factor A , 2002, The EMBO journal.

[11]  Z. Ruggeri,et al.  Induction of platelet thrombi by bacteria and antibodies. , 2002, Blood.

[12]  D. Ferguson,et al.  Functional Blocking of Staphylococcus aureus Adhesins following Growth in Ex Vivo Media , 2002, Infection and Immunity.

[13]  N. Day,et al.  Virulent Combinations of Adhesin and Toxin Genes in Natural Populations of Staphylococcus aureus , 2002, Infection and Immunity.

[14]  M. Byrne,et al.  A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. , 2002, Blood.

[15]  D. Fitzgerald,et al.  Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein SdrE and protein A , 2002, Molecular microbiology.

[16]  T. Foster,et al.  Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. , 2001, The Journal of infectious diseases.

[17]  P. François,et al.  Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis , 2001, Infection and Immunity.

[18]  T. Foster,et al.  The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. , 2001, Microbiology.

[19]  S. Mazmanian,et al.  Sortase‐catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus , 2001, Molecular microbiology.

[20]  J J Sixma,et al.  Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. , 2000, Blood.

[21]  U. Kralisz,et al.  Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods. , 2000, Thrombosis research.

[22]  B. Chong,et al.  Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. , 2000, Blood.

[23]  T. Foster,et al.  Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.

[24]  P. François,et al.  Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus , 1998, Molecular microbiology.

[25]  J. Vermylen,et al.  Recurrent arterial thrombosis linked to autoimmune antibodies enhancing von Willebrand factor binding to platelets and inducing Fc gamma RII receptor-mediated platelet activation. , 1998, Blood.

[26]  T. Foster,et al.  The Fibrinogen-binding MSCRAMM (Clumping Factor) ofStaphylococcus aureus Has a Ca2+-dependent Inhibitory Site* , 1998, The Journal of Biological Chemistry.

[27]  P. François,et al.  The dipeptide repeat region of the fibrinogen‐binding protein (clumping factor) is required for functional expression of the fibrinogen‐binding domain on the Staphylococcus aureus cell surface , 1997, Molecular microbiology.

[28]  L. McIntire,et al.  Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. , 1997, European journal of biochemistry.

[29]  I. Ford,et al.  The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis , 1997, British journal of haematology.

[30]  W. Foss,et al.  Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis , 1996, Infection and immunity.

[31]  W. D. de Vos,et al.  Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin , 1996, Applied and environmental microbiology.

[32]  I. Ford,et al.  Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguis NCTC 7863 , 1996, British journal of haematology.

[33]  P. François,et al.  Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis , 1995, Infection and immunity.

[34]  P. François,et al.  Identification of the ligand‐binding domain of the surface‐located fibrinogen receptor (clumping factor) of Staphylococcus aureus , 1995, Molecular microbiology.

[35]  P. François,et al.  Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus , 1994, Molecular microbiology.

[36]  W. D. de Vos,et al.  Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. , 1993, European journal of biochemistry.

[37]  J. Wells,et al.  Improved cloning vectors and transformation procedure for Lactococcus lactis. , 1993, The Journal of applied bacteriology.

[38]  S. Lord,et al.  The Residues AGDV of Recombinant γ Chains of Human Fibrinogen Must Be Carboxy-Terminal to Support Human Platelet Aggregation , 1992, Thrombosis and Haemostasis.

[39]  E. Davie,et al.  Role of fibrinogen alpha and gamma chain sites in platelet aggregation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Aster,et al.  Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. , 1992, Blood.

[41]  M. Terpenning Infective endocarditis. , 1992, Clinics in geriatric medicine.

[42]  G. Stewart,et al.  Repression and catabolite repression of the lactose operon of Staphylococcus aureus , 1990, Journal of bacteriology.

[43]  F. Götz,et al.  Transformation of Staphylococcus epidermidis and other staphylococcal species with plasmid DNA by electroporation. , 1990, FEMS microbiology letters.

[44]  P. Sullam,et al.  Role of immunoglobulin G in platelet aggregation by viridans group streptococci , 1988, Infection and immunity.

[45]  M. O'Reilly,et al.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage , 1983, Nature.

[46]  P. Henson,et al.  Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. , 1973, The Journal of clinical investigation.

[47]  E. Asheshov Loss of antibiotic resistance in Staphylococcus aureus resulting from growth at high temperature. , 1966, Journal of general microbiology.

[48]  E. Duthie,et al.  Staphylococcal coagulase; mode of action and antigenicity. , 1952, Journal of general microbiology.